Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Karl B Scheidweiler

Showing results (31-40 of 68) with videos related to

Pageof 7
Sort By:
The Journal of Pharmacology and Experimental Therapeutics|October 17, 2003
Pharmacokinetics and pharmacodynamics of methylecgonidine, a crack cocaine pyrolyzateKarl B Scheidweiler, Mark A Plessinger, Jalil Shojaie, et al.
The Journal of Pediatrics|December 6, 2012
Prenatal tobacco exposure, biomarkers for tobacco in meconium, and neonatal growth outcomesSarah K Himes, Laura R Stroud, Karl B Scheidweiler, et al.
Bioanalysis|July 22, 2014
Metabolite profiling of RCS-4, a novel synthetic cannabinoid designer drug, using human hepatocyte metabolism and TOF-MSAdarsh S Gandhi, Mingshe Zhu, Shaokun Pang, et al.
Analytical and Bioanalytical Chemistry|February 13, 2014
Metabolism of synthetic cannabinoids PB-22 and its 5-fluoro analog, 5F-PB-22, by human hepatocyte incubation and high-resolution mass spectrometryAriane Wohlfarth, Adarsh S Gandhi, Shaokun Pang, et al.
Analytical and Bioanalytical Chemistry|March 23, 2010
Validation of a two-dimensional gas chromatography mass spectrometry method for the simultaneous quantification of cannabidiol, Delta(9)-tetrahydrocannabinol (THC), 11-hydroxy-THC, and 11-nor-9-carboxy-THC in plasmaErin L Karschner, Allan J Barnes, Ross H Lowe, et al.
Journal of Chromatography. A|April 17, 2016
Simultaneous quantification of buprenorphine, naloxone and phase I and II metabolites in plasma and breastmilk by liquid chromatography-tandem mass spectrometryMadeleine J Swortwood, Karl B Scheidweiler, Allan J Barnes, et al.
Bioanalysis|June 21, 2014
Metabolism of RCS-8, a synthetic cannabinoid with cyclohexyl structure, in human hepatocytes by high-resolution MSAriane Wohlfarth, Shaokun Pang, Mingshe Zhu, et al.
Drug Testing and Analysis|September 3, 2015
Metabolic characterization of AH-7921, a synthetic opioid designer drug: in vitro metabolic stability assessment and metabolite identification, evaluation of in silico prediction, and in vivo confirmationAriane Wohlfarth, Karl B Scheidweiler, Shaokun Pang, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|August 15, 2009
Effects of dose and route of administration on pharmacokinetics of (+ or -)-3,4-methylenedioxymethamphetamine in the ratMichael H Baumann, Dorota Zolkowska, Insook Kim, et al.
Forensic Toxicology|March 14, 2017
In vitro and in vivo human metabolism of a new synthetic cannabinoid NM-2201 (CBL-2201)Xingxing Diao, Jeremy Carlier, Mingshe Zhu, et al.
Pageof 7

Showing results (31-40 of 68) with videos related to

Sort By:
Pageof 7
The Journal of Pharmacology and Experimental Therapeutics|October 17, 2003
Pharmacokinetics and pharmacodynamics of methylecgonidine, a crack cocaine pyrolyzateKarl B Scheidweiler, Mark A Plessinger, Jalil Shojaie, et al.
The Journal of Pediatrics|December 6, 2012
Prenatal tobacco exposure, biomarkers for tobacco in meconium, and neonatal growth outcomesSarah K Himes, Laura R Stroud, Karl B Scheidweiler, et al.
Bioanalysis|July 22, 2014
Metabolite profiling of RCS-4, a novel synthetic cannabinoid designer drug, using human hepatocyte metabolism and TOF-MSAdarsh S Gandhi, Mingshe Zhu, Shaokun Pang, et al.
Analytical and Bioanalytical Chemistry|February 13, 2014
Metabolism of synthetic cannabinoids PB-22 and its 5-fluoro analog, 5F-PB-22, by human hepatocyte incubation and high-resolution mass spectrometryAriane Wohlfarth, Adarsh S Gandhi, Shaokun Pang, et al.
Analytical and Bioanalytical Chemistry|March 23, 2010
Validation of a two-dimensional gas chromatography mass spectrometry method for the simultaneous quantification of cannabidiol, Delta(9)-tetrahydrocannabinol (THC), 11-hydroxy-THC, and 11-nor-9-carboxy-THC in plasmaErin L Karschner, Allan J Barnes, Ross H Lowe, et al.
Journal of Chromatography. A|April 17, 2016
Simultaneous quantification of buprenorphine, naloxone and phase I and II metabolites in plasma and breastmilk by liquid chromatography-tandem mass spectrometryMadeleine J Swortwood, Karl B Scheidweiler, Allan J Barnes, et al.
Bioanalysis|June 21, 2014
Metabolism of RCS-8, a synthetic cannabinoid with cyclohexyl structure, in human hepatocytes by high-resolution MSAriane Wohlfarth, Shaokun Pang, Mingshe Zhu, et al.
Drug Testing and Analysis|September 3, 2015
Metabolic characterization of AH-7921, a synthetic opioid designer drug: in vitro metabolic stability assessment and metabolite identification, evaluation of in silico prediction, and in vivo confirmationAriane Wohlfarth, Karl B Scheidweiler, Shaokun Pang, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|August 15, 2009
Effects of dose and route of administration on pharmacokinetics of (+ or -)-3,4-methylenedioxymethamphetamine in the ratMichael H Baumann, Dorota Zolkowska, Insook Kim, et al.
Forensic Toxicology|March 14, 2017
In vitro and in vivo human metabolism of a new synthetic cannabinoid NM-2201 (CBL-2201)Xingxing Diao, Jeremy Carlier, Mingshe Zhu, et al.
Pageof 7